Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Statera Biopharma Inc (STAB)

Statera Biopharma Inc (STAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Statera Biopharma Inc 4333 Corbett Drive Suite 1082 FORT COLLINS CO 80525 USA

www.staterabiopharma.com P: 888-613-8802

Description:

Statera BioPharma is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. Statera BioPharma, formerly known as Cytocom Inc., is based in FORT COLLINS, Colo.

Key Statistics

Overview:

Market Capitalization, $K 38
Enterprise Value, $K 8,828
Shares Outstanding, K 54,662
Annual Sales, $ 1,490 K
Annual Net Income, $ -101,850 K
Last Quarter Sales, $ 670 K
Last Quarter Net Income, $ -3,350 K
EBIT, $ -30,890 K
EBITDA, $ -30,630 K
60-Month Beta 0.47
% of Insider Shareholders 5.50%
% of Institutional Shareholders 0.00%
Float, K 51,656
% Float 94.50%
Short Volume Ratio 0.00

Growth:

1-Year Return -96.50%
3-Year Return -99.99%
5-Year Return -99.96%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 01/01/24
Earnings Per Share ttm -0.07
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 129.10%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 01/28/15

STAB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -6,835.57%
Debt/Equity 0.00
Price/Sales 0.01
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.19
Interest Coverage -0.16
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar